APA (7th ed.) Citation

L, S., D, Z., R, T., D, S., X, C., Z, Z., & R, L. (2026). Pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic biomarkers for neuroblastoma risk stratification. Frontiers in immunology, 17, 1831234. https://doi.org/10.3389/fimmu.2026.1831234

Chicago Style (17th ed.) Citation

L, Shi, Zhong D, Tang R, Shao D, Cheng X, Zhang Z, and Liu R. "Pretreatment Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Prognostic Biomarkers for Neuroblastoma Risk Stratification." Frontiers in Immunology 17 (2026): 1831234. https://doi.org/10.3389/fimmu.2026.1831234.

MLA (9th ed.) Citation

L, Shi, et al. "Pretreatment Neutrophil-lymphocyte Ratio and Platelet-lymphocyte Ratio as Prognostic Biomarkers for Neuroblastoma Risk Stratification." Frontiers in Immunology, vol. 17, 2026, p. 1831234, https://doi.org/10.3389/fimmu.2026.1831234.